{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:22:07Z","timestamp":1788193327693,"version":"build-2803163510"},"reference-count":14,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215110001921_sec1\"><jats:title>Objectives:<\/jats:title><jats:p>Epistaxis can be caused or exacerbated by anticoagulant and antiplatelet therapy. This prospective study assessed the prevalence of epistaxis in patients taking anticoagulant and antiplatelet medication, and monitored differences in patients\u2019 clinical courses.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215110001921_sec2\"><jats:title>Method:<\/jats:title><jats:p>Prospective data were collected for consecutive patients referred with epistaxis from the emergency department over a seven-month period. Emergency department records were used to investigate prevalence and referral rates.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215110001921_sec3\"><jats:title>Results:<\/jats:title><jats:p>Over the study period, 290 patients presented to the emergency department with epistaxis; this represented 0.9 per cent of all emergency attendances. Of these patients, 119 (39 per cent) were referred on to the ENT department, 62 per cent of whom were currently taking anticoagulant or antiplatelet medication. Patients taking anticoagulant and antiplatelet medication were a significantly older group (relative risk 1.50 (1.08\u20132.28),<jats:italic>p<\/jats:italic>\u00a0=\u00a00.01) requiring longer in-patient stays (relative risk 2.50 (1.01\u20134.97),<jats:italic>p<\/jats:italic>\u00a0=\u00a00.01) and more aggressive local haemostasis measures. Most patients taking warfarin had an international normalised ratio outside the appropriate range for their disease. Hypertension was not a factor in these patients\u2019 clinical course.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215110001921_sec4\"><jats:title>Conclusion:<\/jats:title><jats:p>Increasingly, emergency and ENT departments are being presented with epistaxis in patients taking anticoagulant or antiplatelet medication. A better understanding of such medication and its effects may enable more effective management of these patients.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215110001921","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T09:39:36Z","timestamp":1284629976000},"page":"38-42","source":"Crossref","is-referenced-by-count":69,"title":["Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study"],"prefix":"10.1017","volume":"125","author":[{"given":"J","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rainsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"S0022215110001921_ref7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MOO.0b013e32814b06ed","article-title":"Update on epistaxis","volume":"15","author":"Wormald","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"S0022215110001921_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-010-0349-x"},{"key":"S0022215110001921_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199701000-00007"},{"key":"S0022215110001921_ref6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02907666","article-title":"Epistaxis: A retrospective clinical study","volume":"57","author":"Varshney","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"S0022215110001921_ref4","first-page":"312","article-title":"The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom","volume":"53","author":"Hollowell","year":"2003","journal-title":"Brit J Gen Pract"},{"key":"S0022215110001921_ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890010051009"},{"key":"S0022215110001921_ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.653048"},{"key":"S0022215110001921_ref14","first-page":"542","article-title":"Warfarin and epistaxis: should warfarin always be discontinued?","volume":"22","author":"Srinivasen","year":"1997","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"S0022215110001921_ref5","unstructured":"5 The management of atrial fibrillation. In: http:\/\/guidance.nice.org.uk\/CG36 [5 January 2010]"},{"key":"S0022215110001921_ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-1-200501040-00006"},{"key":"S0022215110001921_ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.11.1612"},{"key":"S0022215110001921_ref10","first-page":"59","article-title":"Endoscopic treatment of posterior epistaxis","volume":"36","author":"Frikart","year":"1998","journal-title":"Rhinology"},{"key":"S0022215110001921_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(95)70169-9"},{"key":"S0022215110001921_ref2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.025007"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215110001921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T02:15:25Z","timestamp":1636510525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215110001921\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0022215110001921"],"URL":"https:\/\/doi.org\/10.1017\/s0022215110001921","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,16]]}}}